Category: Pharma

Interview with CorEvitas CEO Raymond Hill

published date
April 8th, 2021 by

Ray Hill photo 1582212832315
Ray Hill, CorEvitas CEO

Ray Hill grew up on a farm and took up rowing in college. So he’s always been a hard worker and an early riser. In this edition of the HealthBiz podcast, Ray brings us up to date on progress at CorEvitas. As CEO and Chairman he’s led the company’s expansion from a singular rheumatoid arthritis registry to a broader autoimmune and inflammatory company with registries, real world evidence, biorepositories, and patient engagement capabilities.

I was partial to the company’s former name, Corrona, but for some reason that one didn’t have the right connotations for the pandemic era. When not focused on CorEvitas, Ray continues to row and to cycle. And he’s also chair of Row New York, which combines rowing and academics for kids who not otherwise have access.  Ray is proud of Row NY’s 99% graduation rate from HS and 85% graduation rate from four year colleges, a remarkable record.

 Meanwhile, If your business needs strategy consulting support please reach out to me at dwilliams@HealthBusinessGroup.com. We have experience throughout healthcare and life sciences, including with real world evidence companies similar to CorEvitas. 

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with Joel Morse, Curavit CEO

published date
March 4th, 2021 by

joel opening pittston
Joel Morse, Curavit CEO

Joel Morse has devoted his career to building innovative companies that serve the pharmaceutical industry. His latest venture, Curavit Clinical Research runs decentralized or virtual trials, which have grown dramatically in the pandemic. 

I’m a big fan –and will be a panelist on a Curavit-sponsored webinar:  Are You Ready to Go Virtual? Unlocking the Full Potential of Decentralized Clinical Trials.  The webinar is on March 11 at 1 pm EST. Register here.

In this episode of the HealthBiz podcast, Joel talks about decentralized trials and why they’re growing. He also opens up about his experience building C3i, and how it led him to adventures around the world, including Joel’s involvement with the royal family in Bulgaria.

Check out the rough (AI generated) transcript.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.


By healthcare business consultant David E. Williams, president of Health Business Group.

COVID-19 vaccinations are going poorly in MA. I’m quoted in the Boston Globe

published date
January 29th, 2021 by

For months we’ve been focused on the shortage of COVID-19 vaccine doses. That’s still a problem, but for now the bottlenecks are further downstream. Massachusetts is struggling to get the doses distributed and administered. More than half sit unused. Even if we have 10 million (or a billion) doses we’d still be stuck.

In today’s Boston Globe (State’s hope of vaccinating almost everyone by the end of summer depends on a lot going right) I encourage the state to assume there will be enough vaccines and just get them out to people.

“We’re only using half of what we’ve been given,” said David Williams, president of Health Business Group, a Boston management consulting firm. “It’s not an excuse to say because supplies are slow, we can just sit back. We should assume there’ll be more supply, and we owe it to the citizens of Massachusetts to be ready when it comes.”


By healthcare business consultant David E. Williams, president of Health Business Group.

Javara CEO Jennifer Byrne Talks Clinical Trials and Integrated Research

published date
January 21st, 2021 by

Jennifer Byrne photo
Javara CEO, Jennifer Byrne

Jennifer Byrne has spent her whole career in clinical trials, working on more than 8000 studies. So she knows a thing or two about the needs of pharma sponsors, clinical sites and patients. As founder and CEO of Javara, Jennifer is spearheading a new concept: the integrated research organization or IRO, a novel model for bringing clinical research into the healthcare ecosystem.

In this episode of the HealthBiz podcast, Jennifer shares her journey –how it was influenced at various times by her father and her mother, and what she sees coming in the post-pandemic era.

Jennifer is a big reader. She’s currently re-reading Jesse Itzler’s Living with a SEAL. He’s a serial entrepreneur who’s married to the founder of Spanx. She’s always reading the Power of Habit: Why We Do What We Do In Life And Business by Charles Duhigg.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle Podcasts and  many more services. Please consider rating the podcast on Apple Podcasts. Doing so helps the podcast reach more listeners.

Check out the rough (AI generated) transcript.

—-

By healthcare business consultant David E. Williams, president of Health Business Group.

ICER founder Dr. Steve Pearson explains COVID-19 remdesivir pricing model

published date
November 12th, 2020 by

Steve scaled e1603726353244
Dr. Steve Pearson

Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with.

In this episode of the HealthBiz podcast, Steve describes how the Institute for Clinical and Economic Review (ICER) compiles and analyzes clinical evidence to estimate the fair value of treatments for cancer and other serious illnesses. ICER has been especially active during the pandemic, developing a pricing model for remdesivir and other COVID-19 therapies that’s being used in the United States and by health technology assessment agencies around the world.

For fun, he has been reading Paradise Lost by John Milton.

This is the second episode I’ve recorded on COVID-19 drug pricing. Check out the first one: Remdesivir powers activate! with Dr. Surya Singh.

The HealthBiz podcast is now on SpotifyApple PodcastsGoogle Podcasts and  many more services, making it easy to subscribe.

Below is a rough (AI-generated) transcript of the episode.



—–

By healthcare business consultant David E. Williams, president of Health Business Group